Ipamorelin vs GHK-Cu
A comprehensive, data-driven comparison of Ipamorelin (NNC 26-0161) and GHK-Cu (Copper Peptide). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Ipamorelin NNC 26-0161 | GHK-Cu Copper Peptide, GHK-Copper |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Not submitted |
| Category | Growth Hormone | Anti-Aging |
| Primary Use | Growth hormone optimization | Skin rejuvenation and anti-aging |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $30 - $150/mo |
| Administration | Subcutaneous injection | Topical |
| Typical Dose | 200-300mcg 2-3x daily | 1-2% topical cream daily, or 1-2mg injection |
| Frequency | Daily | Daily |
| Mechanism | Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH release without affecting cortisol or prolactin | Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and has antioxidant properties |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Moderate |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Ipamorelin is generally more affordable ($35 - $70/mo) compared to GHK-Cu ($30 - $150/mo).
- 2Ipamorelin is administered via subcutaneous injection, while GHK-Cu uses topical.
- 3GHK-Cu has moderate-quality evidence, while Ipamorelin has emerging-quality evidence.
- 4They belong to different categories: Ipamorelin (Growth Hormone) vs GHK-Cu (Anti-Aging).
Which Is Better For...
Ipamorelin
More budget-friendly option with lower monthly costs
GHK-Cu
Fewer commonly reported side effects
GHK-Cu
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Ipamorelin | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
| GHK-Cu | $30 - $150/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. GHK-Cu works via Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and. They differ in FDA approval status, efficacy data, and cost.
Ipamorelin typically costs $35 - $70/mo, while GHK-Cu costs $30 - $150/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). GHK-Cu is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Common side effects of GHK-Cu include Mild skin irritation (topical), Injection site reactions, Temporary copper taste. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Ipamorelin is a pentapeptide that selectively stimulates growth hormone release by mimicking ghrelin, the hunger hormone. Unlike many other GH secretagogues, ipamorelin does not significantly increase...
View Full Ipamorelin GuideGHK-Cu is a naturally occurring copper-binding peptide found in human plasma that declines with age. It has been extensively studied for skin rejuvenation due to its ability to stimulate collagen and ...
View Full GHK-Cu GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Ipamorelin and GHK-Cu should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.